| P50 | author | Chaoshu Tang | Q123255590 |
| P2093 | author name string | Yongfen Qi | |
| | Jack Chen | |
| | Xinhua Yin | |
| | Dongming Hou | |
| | Gaigai Zhang | |
| | Lakshmana Pendyala | |
| P2860 | cites work | Central ghrelin modulates sympathetic activity in conscious rabbits | Q78460999 |
| | Splanchnic release of ghrelin in humans | Q78945811 |
| | C-terminal pro-ghrelin peptides are present in the human circulation | Q79106012 |
| | Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells | Q79359834 |
| | Association between ghrelin and cardiovascular indexes in healthy obese and lean men | Q79369737 |
| | Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats | Q79824044 |
| | Endogenous ghrelin increases in adriamycin-induced heart failure rats | Q80058433 |
| | Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells | Q80204181 |
| | Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome | Q80257881 |
| | Effect of ghrelin on human endothelial cells apoptosis induced by high glucose | Q80844026 |
| | Circulating ghrelin levels in obese women: a possible association with hypertension | Q80973643 |
| | Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells | Q81239492 |
| | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| | Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes | Q24293908 |
| | Intracoronary ghrelin infusion decreases coronary blood flow in anesthetized pigs | Q28274489 |
| | International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function | Q28289212 |
| | Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone | Q28504894 |
| | Deletion of Ghrelin Impairs neither Growth nor Appetite | Q28505729 |
| | Is microvascular flow rate related to ghrelin, leptin and adiponectin levels? | Q31035957 |
| | Growth hormone-releasing peptides and the cardiovascular system | Q33903329 |
| | Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. | Q34229787 |
| | Ghrelin: structure and function | Q34406050 |
| | Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans | Q34511955 |
| | Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. | Q34677468 |
| | [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis | Q35043705 |
| | Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. | Q35044504 |
| | Neural regulation of blood pressure by leptin and the related peptides | Q35165383 |
| | Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin | Q35794412 |
| | Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies | Q36283920 |
| | Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system | Q36323126 |
| | The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease | Q36417549 |
| | Biological, physiological, and pharmacological aspects of ghrelin | Q36447933 |
| | The physiology and potential clinical applications of ghrelin, a novel peptide hormone | Q36480912 |
| | Metabolic and immunologic derangements in cardiac cachexia: where to from here? | Q36526900 |
| | Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone | Q36576963 |
| | A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both? | Q36707004 |
| | Physiological, pathological and potential therapeutic roles of ghrelin. | Q36774595 |
| | Emerging results of anticatabolic therapy with ghrelin | Q36783604 |
| | Heart failure and cachexia: insights offered from molecular biology. | Q36991787 |
| | Structure and function of ghrelin | Q37056267 |
| | Ghrelin and metabolic disorders | Q37411490 |
| | Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation. | Q38298687 |
| | Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells | Q40038434 |
| | Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. | Q40810018 |
| | Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling | Q41934541 |
| | Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells | Q42460970 |
| | Stimulation of cardiac protein synthesis by insulin-like growth factors | Q42793218 |
| | Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism. | Q42829069 |
| | Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. | Q42918384 |
| | Hemodynamic and hormonal effects of human ghrelin in healthy volunteers | Q43569505 |
| | Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors | Q43774896 |
| | Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure | Q43819858 |
| | Growth hormone treatment in dilated cardiomyopathy | Q43839514 |
| | Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects | Q44435391 |
| | Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans | Q44457632 |
| | Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes | Q44599802 |
| | Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats | Q44612283 |
| | Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart | Q44615501 |
| | Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro | Q44654247 |
| | Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart | Q44723431 |
| | Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats | Q44781986 |
| | Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion | Q44895710 |
| | Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. | Q45032146 |
| | Ghrelin protects myocardium from isoproterenol-induced injury in rats. | Q45038202 |
| | Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease | Q45100272 |
| | Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure | Q45166636 |
| | Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients | Q46223805 |
| | Contractile effect of ghrelin on isolated guinea-pig renal arteries | Q46252243 |
| | Nitric oxide synthase inhibition exaggerates the hypotensive response to ghrelin: role of calcium-activated potassium channels | Q46388252 |
| | Selected hormones levels in individuals with endothelial dysfunction and insulin resistance | Q46470134 |
| | Ghrelin blunted vascular calcification in vivo and in vitro in rats | Q46520454 |
| | GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure | Q46542056 |
| | Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. | Q46627102 |
| | Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms | Q46654440 |
| | Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects | Q46677653 |
| | Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. | Q46754090 |
| | Ghrelin improves endothelial function in patients with metabolic syndrome | Q46783985 |
| | Dose dependent effects of ghrelin on pentylenetetrazole-induced oxidative stress in a rat seizure model | Q46794448 |
| | Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation | Q46874141 |
| | Contractile effects of Ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium | Q46883498 |
| | Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction | Q46892291 |
| | Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. | Q46897690 |
| | Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats | Q46966291 |
| | In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. | Q46967733 |
| | Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats | Q46989966 |
| | Preproghrelin Leu72Met polymorphism in Chinese subjects with coronary artery disease and controls | Q46990131 |
| | The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content | Q47755019 |
| | A Growth Hormone Secretagogue Prevents Ischemic-Induced Mortality Independently of the Growth Hormone Pathway in Dogs with Chronic Dilated Cardiomyopathy | Q47908756 |
| | Association between ghrelin gene variations and blood pressure in subjects with impaired glucose tolerance | Q48433267 |
| | The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans | Q50336243 |
| | Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. | Q51496026 |
| | Ghrelin in vitro modulates vasoactive factors in human umbilical vein endothelial cells. | Q51758003 |
| | Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. | Q51830175 |
| | GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy. | Q52042600 |
| | The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. | Q54067380 |
| | Growth Hormone Improves Cardiac Performance in Experimental Heart Failure | Q54167656 |
| | Growth hormone secretagogue binding sites in peripheral human tissues. | Q54414034 |
| | Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease | Q57315156 |
| | Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension | Q57912877 |
| | Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles | Q57912878 |
| | Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat | Q58809303 |
| | A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy | Q60660870 |
| | Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation | Q71102911 |
| | Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses | Q72662305 |
| | Identification and characterization of a new growth hormone-releasing peptide receptor in the heart | Q73111084 |
| | Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin | Q73879575 |
| | Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure | Q74522887 |
| | Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy | Q77773159 |
| P433 | issue | 1 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 62-70 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Current cardiology reviews | Q26842280 |
| P1476 | title | Ghrelin and cardiovascular diseases | |
| P478 | volume | 6 | |